The proximal promoter region of the gene encoding human 17β- hydroxysteroid dehydrogenase type 1 contains GATA, AP-2, and Sp1 response elements: Analysis of promoter function in choriocarcinoma cells

Endocrinology

Volumn 138, Issue 8, 1997, Pages 3417-3425

  Piao, Yun Shang ^a   Peltoketo, Hellevi ^a   Vihko, Pirkko ^a   Vihko, Reijo ^a  

^a UNIVERSITY OF OULU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; BINDING SITE; CHORIOCARCINOMA; DNA FLANKING REGION; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; GENE MUTATION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SILENCER GENE; TUMOR CELL CULTURE;

EID: 0030788946     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.8.5329     Document Type: Article

References (45)

1. Labrie F 1991 At the cutting edge: intracrinology. Mol Cell Endocrinol 78:C113-C118
2. Peltoketo H, Isomaa V, Mäentausta O, Vihko R 1988 Complete amino acid sequence of human placental 17β-hydroxysteroid dehydrogenase deduced from cDNA. FEBS Lett 239:73-77
3. Luu-The V, Labrie C, Zhao HF, Couët J, Lachance Y, Simard J, Leblanc G, Côté J, Bérubé D, Gagné R, Labrie F 1989 Characterization of cDNAs for human estradiol 17β-dehydrogenase and assignment of the gene to chromosome 17: evidence of two mRNA species with distinct 5′-termini in human placenta. Mol Endocrinol 3:1301-1309
4. Wu L, Einstein M, Geissler WM, Chan HK, Elliston KO, Andersson S 1993 Expression cloning and characterization of human 17β-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20α-hydroxysteroid dehydrogenase activity. J Biol Chem 268:12964-12969
5. Geissler WM, Davis DL, Wu L, Bradshaw KD, Patel S, Mendonca BB, Elliston KO, Wilson JD, Russel DW, Andersson S 1994 Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3. Nat Genet 7:34-39
6. Adamski J, Normand T, Leenders F, Monte D, Begue A, Slehelin D, Jungblut PW, de Launoit Y 1994 Molecular cloning of a novel widely expressed human 80 kDa 17β-hydroxysteroid dehydrogenase IV. Biochem J 311:437-443
7. Tremblay Y, Ringler GE, Morel Y, Mohandas TK, Labrie F, Strauss III JF, Miller WL 1989 Regulation of the gene for estrogenic 17-ketosteroid reductase lying on chromosome 17cen->q25. J Biol Chem 264:20458-20462
8. Ghersevich S, Poutanen M, Martikainen H, Vihko R 1994 Expression of 17β-hydroxysteroid dehydrogenase in human granulosa cells: correlation with follicular size, cytochrome P-450 aromatase activity and oestradiol production. J Endocrinol 143:139-150
9. Beaudoin C, Blomquist CH, Tremblay Y 1995 Gene expression of 17β-hydroxysteroid dehydrogenase type 2 isozyme in primary cultures of human trophoblasts predicts different mechanisms regulating type 1 and type 2 enzymes. Endocrinology 136:3807-3814
10. Poutanen M, Isomaa V, Lehto V-P, Vihko R 1992 Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue. Int J Cancer 50:386-390
11. Miettinen MM, Mustonen MVJ, Poutanen MH, Isomaa VV, Vihko RK 1996 Human 17β-hydroxysteroid dehydrogenase type 1 and type 2 isoenzymes have opposite activities and characteristic cell- and tissue-specific expression. Biochem J 314:839-845
12. Mäentausta O, Sormunen R, Isomaa V, Lehto V-P, Jouppila P, Vihko R 1991 Immunohistochemical localization of 17β-hydroxysteroid dehydrogenase (17HSD) in the human endometrium during the menstrual cycle. Lab Invest 65:582-587
13. Miettinen MM, Poutanen MH, Vihko RK 1996 Characterization of estrogen-dependent growth of cultured MCF-7 human breast cancer cells expressing 17β-hydroxysteroid dehydrogenase type 1. Int J Cancer 68:600-604
14. LuuThe V, Labrie C, Simard J, Lachance Y, Zhao H-F, Couët J, Leblanc G, Labrie F 1990 Structure of two in tandem human 17β-hydroxysteroid dehydrogenase genes. Mol Endocrinol 4:268-275
15. Peltoketo H, Isomaa V, Vihko R 1992 Genomic organization and DNA sequences of human 17β-hydroxysteroid dehydrogenase genes and flanking regions: localization of multiple Alu sequences and putative cis-acting elements. Eur J Biochem 209:459-466
16. Winqvist R, Peltoketo H, Isomaa V, Grzeschik K-H, Mannermaa A, Vihko R 1990 The gene for 17β-hydroxysteroid dehydrogenase maps to human chromosome 17, bands q12-q21, and shows an RFLP with ScaI. Hum Genet 85:473-476
17. Simard J, Feunteun J, Lenoir G, Tonin P, Normand T, Luu The V, Vivier A, Lasko D, Morgan K, Rouleau GA, Lynch H, Labrie F, Narod SA 1993 Genetic mapping of the breast-ovarian cancer syndrome to a small interval on chromosome 17q12-21 exclusion of candidate genes EDH17B2 and RARA. Hum Mol Genet 2:1193-1199
18. Poutanen M, Moncharmont B, Vihko R 1992 17β-Hydroxysteroid dehydrogenase gene expression in human breast cancer cells: regulation of expression by a progestin. Cancer Res 52:290-294
19. Jantus-Lewintre E, Orava M, Peltoketo H, Vihko R 1994 Characterization of 17β-hydroxysteroid dehydrogenase type 1 in choriocarcinoma cells: regulation by basic fibroblast growth factor. Mol Cell Endocrinol 104:1-9
20. Jantus-Lewintre E, Orava M, Vihko R 1994 Regulation of 17β-hydroxysteroid dehydrogenase type 1 by epidermal growth factor and transforming growth factor alpha in choriocarcinoma cells. Endocrinology 135:2629-2634
21. Piao Y-S, Peltoketo H, Jouppila A, Vihko R 1997 Retinoic acids increase 17β-hydroxysteroid dehydrogenase type 1 expression in JEG-3 and T47D cells, but the stimulation is potentiated by epidermal growth factor, 12-O-tetradeacanoylphorbol-13-acetate, and cyclic adenosine 3′,5′-monophosphate only in JEG-3 cells. Endocrinology 138:898-904
22. Ritvos O, Voutilainen R 1992 Regulation of aromatase cytochrome P-450 and 17β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels in choriocarcinoma cells. Endocrinology 130:61-67
23. Tremblay Y, Beaudoin C 1993 Regulation of 3β-hydroxysteroid dehydrogenase and 17β-hydroxysteroid dehydrogenase messenger ribonucleic acid levels by cyclic adenosine 3′,5′-monophosphate and phorbol myristate acetate in human choriocarcinoma cells. Mol Endocrinol 7:355-364
24. Piao Y-S, Peltoketo H, Oikarinen J, Vihko R 1995 Coordination of transcription of human 17β-hydroxysteroid dehydrogenase type 1 gene (EDH17B2) by a cell-specific enhancer and a silencer: identification of a retinoic acid response element. Mol Endocrinol 9:1633-1644
25. Henikoff S 1984 Unidirectional digestion with exonuclease III creates targeted break points for DNA sequencing. Gene 28:351-359
26. Ho SN, Hunt HD, Horton RM, Pullen JK, Pease LR 1989 Site-directed mutagenesis by overlap extension using the polymerase chain reaction. Gene 77:51-59
27. Neumann JR, Morency CA, Russian KO 1987 A novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5:444-447
28. Eastman A 1987 An improvement to the novel rapid assay for chloramphenicol acetyltransferase gene expression. Biotechniques 5:731
29. Dignam JD, Lebovitz RM, Roeder RG 1983 Accurate transcription initiation by RNA polymerase II a soluble extract from isolated mammalian nuclei. Nucleic Acids Res 11:1475-1489
30. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K 1989 Current Protocols in Molecular Biology. Green Publishing Associates and Wiley Interscience, New York, pp 12.1.1-12.1.4
31. Bugge TH, Pohl J, Lonnoy O, Stunnenberg HG 1992 RXRα, a promiscuous partner of retinoic acid and thyroid hormone receptors. EMBO J 11:1409-1418
32. Steger DL, Hecht JH, Mellon PL 1994 GATA-binding proteins regulate the human gonadotropin α-subunit gene in the placenta and pituitary gland. Mol Cell Biol 14:5592-5602
33. Hagen G, Müller S, Beato M, Suske G 1992 Cloning by recognition site screening of two novel GT box binding proteins: a family of Sp1 related genes. Nucleic Acids Res 20:5519-5525
34. Li Y, Mak G, Franza BR 1994 In vitro study of functional involvement of Sp1, NF-κB/Rel, and AP1 in phorbol 12-myristate 13-acetate mediated HIV-1 long terminal repeat activation. J Biol Chem 269:30616-30619
35. Lecointe N, Bernard O, Naert K, Joulin V, Larsen CJ, Romeo PH, Mathieu-Mahul D 1994 GATA- and Sp1-binding sites are required for the full activity of the tissue-specific promoter of the tal-1 gene. Oncogene 9:2623-2632
36. Ström A-C, Forsberg M, Lillhager P, Westin G 1996 The transcription factors Sp1 and Oct-1 interact physically to regulate human U1 snRNA gene expression. Nucleic Acids Res 24:1981-1986
37. Jiang S-W, Shepard AR, Eberhardt NL 1995 An initiator element is required for maximal human chorionic somatomammotropin gene promoter and enhancer function. J Biol Chem 270:3683-3692
38. Hagen G, Müller S, Beato M, Suske G 1994 Sp1-mediated transcriptional activation is repressed by Sp3. EMBO J 13:3843-3851
39. Birnbaum MJ, van Wijnen AJ, Odgren PR, Last TJ, Suske G, Stein GS, Stein JL 1995 Sp1 trans-activation of cell cycle regulated promoters is selectively repressed by Sp3. Biochemistry 34:16503-16508
40. Dennig J, Beato M, Suske G 1996 An inhibitor domain in Sp3 regulates its glutamine-rich activation domains. EMBO J 15:5659-5667
41. Udvadia AJ, Templeton DJ, Horowitz JM 1995 Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proc Natl Acad Sci USA 92:3953-3957
42. Imagawa M, Chiu R, Karin M 1987 Transcription factor AP-2 mediates induction by two different signal-transduction pathway: protein kinase C and cAMP. Cell 51:251-260
43. Simon MC 1995 Gotta have GATA. Nat Genet 11:9-11
44. Bockamp EO, McLaughlin F, Murrell A, Green AR 1994 Transcription factors and the regulation of haemopoiesis: lessons from GATA and SCL proteins. Bioassays 16:481-488
45. Ng Y-K, George KM, Engel JD, Linzer DIH 1994 GATA factor activity is required for the trophoblast-specific transcriptional regulation or the mouse placental lactogen I gene. Development 120:3257-3266